Islamic Republic of Afghanistan Ministry of Public Health General Directorate of Preventive Medicine Communicable Diseases Control Directorate National Malaria and Leishmaniasis Control Programme



Download 5.6 Mb.
Page8/8
Date28.05.2018
Size5.6 Mb.
#52328
1   2   3   4   5   6   7   8

ANNEX 5 Timetable of activities

The quarterly plan of implementation of the activities outlined in the CBMM Strategy is provided in the Table below.







Year 1

Year 2

Year 3

Year 4

Year 5




Q

1


Q

2


Q

3


Q

4


Q

1


Q

2


Q

3


Q

4


Q

1


Q

2


Q

3


Q

4


Q

1


Q

2


Q

3


Q

4


Q

1


Q

2


Q

3


Q

4


Programme planning and management




Writing TORs for malaria CBMM coordinator

X


























































Appoint malaria CBMM

Coordinator



X


























































Development of Guidelines




Case management of fever

X


























































Fever management algorithms

X


























































RDT quality assurance at point of care

X


























































RDT transport and storage methods

X


























































Develop IEC materials

X


























































RDT procurement and logistics




RDT, gloves, sharp boxes procurement

X










X










X










X










X










Receive RDTs (staggered delivery)

X




X




X




X




X




X




X




X




X




X




Distribution of RDT and other supplies to the field




X




X




X




X




X




X




X




X




X




X

ACT procurement and logistics




ACT procurement

X










X










X










X










X










Receive ACTs (staggered delivery)

X




X




X




X




X




X




X




X




X




X




Distribution of ACTs to the field




X




X




X




X




X




X




X




X




X




X

RDT Quality Assurance





Write SOPs and Job Aids for RDTs

X


























































RDT Post-shipment lot-testing (as appropriate)

X










X










X










X










X










Training




Develop training tools for RDTs and ACTs

X



























































Develop training tools for supervisors

X


























































Conduct Training of Trainers courses




X










X










X










X










X







Training of health workers and supervisors




X

X







X

X







X

X







X

X







X

X




Communication




Community sensitization







X

X

X

X

X

X

X

X

X

X

X

X

X

X

X

X

X

X

Supervision




Regular supervision







X

X

X

X

X

X

X

X

X

X

X

X

X

X

X

X

X

X

Monitoring and evaluation




Review record forms and procedures

X


























































Monitoring outcome indicators







X

X

X

X

X

X

X

X

X

X

X

X

X

X

X

X

X

X

Operational Research




Introduction of RDTs in DH and CBC













X

X

X

X





































Evaluating incentive schemes for CHWs

























X

X

X

X

























Malaria treatment seeking behaviour





































X

X

X

X















ANNEX 6 Budget components and financial gaps (USD)

The annual budget (in USD) for the main activities outlined in the CBMM Strategy are presented in the Table below. Funding for commodities which are already supplied by BPSH are not included, i.e. for the procurement and distribution of chloroquine, primaquine and antibiotics for the management of non-malaria fevers of bacterial origin. The funding gap has been calculated only for years 1 and 2, in view of the firm commitment from the GFR8.




Activity

Year 1

Year 2

Year 3

Year 4

Year 5

Development of Guidelines




Guidelines for RDT transport and storage

10,000













Fever management algorithm

5,000













Supervision checklists and temp. charts

5,000













RDT procurement and supply management




RDT, gloves, sharp boxes procurement

111,350

171,982

284,228

389,978

389,978

Distribution of RDT and other supplies to the field (10%)

11,135

17,198

28,423

38,998

38,998

ACT procurement and supply management




ACT procurement

11,329

17,497

28,918

39,677

39,677

Distribution of ACTs to the field (10%)

1,133

1,750

2,892

3,968

3,968

RDT Quality Assurance




Post-shipment lot-testing of RDTs (as appropriate)

100

100










Training




Instructions and training manual for supervisors

5'000













Training of trainers

4,620

36,805

42,644

26,991

26,991

Training of health workers

4,896

42,982

42,670

32,559

31,452

Training of supervisors

574

4,563

5,286

3,346

3,346

Communication




Community sensitization

(health forum)



3,000

129,300

129,300

221,680

221,680

Supervision




Regular supervision

4,920

38,880

12,660

29,880

44,220

Monitoring and evaluation




Develop record forms, survey procedures

10,000













Health facility survey for outcome indicators

5,000

5,000

5,000

5,000

5,000

OR: introduction of RDTs in DH and CBC




20,000










OR: evaluating incentive schemes for CHWs







25,000







OR: malaria treatment seeking behaviour










20'000




TOTAL

FUNDS REQUIRED



188,057

486,056

607,021

792,077

805,310

BUDGET AVAILABLE

(R8 GF malaria)*



392,573

656,528

551,610

565,313

579,701

FINANCIAL GAP

-204,516

-170,472

55,411

226,764

225,609

* calculated from approved funding Global Fund R8 malaria grant

The total core budget required to implement the 5 years strategy is USD 2,878,521. Considering the total funding available to implement the GF R8 grant, amounting to USD 2,745,725 the funding gap amounts to USD 132,796 for the 5 years implementation of the CBMM Strategy.



ANNEX 7: CBMM training Curriculum


Contents


  1. Background

  2. Introduction of CBMM

  • What is CBMM

  • What CBMM offers

  • Why CBMM

  • CBMM providers

  • Components of CBMM

  • Why CHW training on CBMM

  1. Necessity of the curriculum

  2. Contents of the curriculum

Chapter one:

General information about malaria



  • What is malaria

  • Signs & symptoms of malaria

  • Causative agents of malaria

  • Vector of malaria

  • Mode of transmission of malaria

  • Diagnosis of malaria

  • Prevention of malaria

Chapter two:

Introduction of RDT



  • What is RDT

  • Advantage and disadvantage of RDT

  • Procedure of RDT use

  • Storage of RDT

Chapter three:

Practical use of RDT



  • Technique of blood collection from patient’s finger

  • Use of RDT for malaria diagnosis

  • Interpretation of the result of RDT

Chapter four:

Treatment of malaria



  • Introduction of ACT

  • Treatment of malaria by using ACT

  • flow chart of Malaria treatment

Chapter five:

Sessions of the training



  • Objective of the session

  • Methods of lesson

  • Topic of the session

  • Materials

Annex

  1. Annex a - Instructions for the training

  2. Annex b – Training schedule

  3. Annex c- Pre-test

  4. Annex d- Post-test

  5. Annex e- pictorial instruction for RDT use

  6. Annex f- Malaria Treatment Dosage Chart

  7. Annex g- RDT follow up tally sheet

  8. Annex h- RDT monthly Aggregated report

  9. Annex i- ACT use tally sheet

  10. Annex j- Monthly report on ACT use

  11. Annex k - Referral form

Background
Malaria is an endemic disease and a major public health problem in many Provinces of Afghanistan. It causes a great burden on the health and economic development of individuals, families and communities living in endemic areas. The total number of reported malaria cases were 427,743 1n 2006, 390729 in 2009 and 390121 in 2010. Majority of these cases were clinically diagnosed: 79.77%, 83.40% and 80.04% respectively(HMIS 2010). The Government of Afghanistan remains committed to the control of this disease. For this purpose the Government developed the National Malaria Strategy Plan 2008-2013 with a vision of a malaria free Afghanistan. Two priority targets mentioned in NMSP 2008-2013 include:

  • By the end of 2013, 60% of targeted Health Posts will be able to diagnose malaria by RDTs

  • By the end of 2009, in order to strengthen malaria control at the community level, the NMLCP and all PMLCPs will have a Community-Based Component including Home Management of Malaria (CBMM)


Introduction of CBMM-
What is CBMM (Community Based Management of Malaria)

It is a care delivery strategy at community level to diagnose and provide effective treatment for uncomplicated plasmodium falciparum malaria which will reduce the burden of morbidity and mortality due to malaria in endemic areas.


What CBMM offers?

At present at health post level CHWs have Sulfadoxine Pyrimethamine and Chloroquine in their kit to treat malaria. CHWs are treating malaria without any confirmed diagnosis. CBMM approach will include RDTs and ACTs in their kits along with SP and Chloroquine. RDTs will be used for rapid diagnosis of malaria and ACTs will be used to treat confirm uncomplicated falciparum malaria cases.


Why CBMM?
The Government of Afghanistan is committed to provide health care services to the entire nation to improve the health condition of the people. But unfortunately in some geographical areas communities are remotely located from the health facilities limiting access to health services. During 2010, 31,2267 malaria cases were clinically diagnosed throughout Afghanistan from which 137,670 cases i.e. 40.08% were clinically diagnosed at health post level. Therefore CBMM will play a pivotal role in confirming malaria diagnosis at health post level up to households. This will limit the excess use of Chloroquine & SP as well as prevent resistance (plasmodium falciparum) to Sulfadoxine Pyrimethamine. In addition to the treatment, CHWs will be able to differentiate the severe cases and refer to health facilities for proper management. This strategy will assist weak health care systems, where women and children cannot reach health facilities and where self-treatment is common and often misguided.
CBMM providers:


  • Community Health Workers will provide specific health care services (diagnosis using RDT and treatment via ACT) at health post level.

  • Community Health Supervisors will monitor and supervise activities of the CHWs


Component of CBMM

  • Diagnosis of malaria by using RDT test

  • Treatment of uncomplicated Plasmodium falciparum malaria by ACT


Why CHWs training on CBMM?

A health post operates as a basic health service is delivered by the CHW. This grassroots level health service delivery point is ideally staffed by one male and one female CHW. CHWs provide care to an average of 27% of the total number of outpatients visiting the health facilities (2008). The numbers of outpatients have increased with the expansion of health posts as a result of which over the past two years, the numbers seen per health post have increased by 50%. Unlike health facilities, there is no decline in visits during the winter months, 40% - 45% of childhood illnesses are managed by CHWs. (CBHC Policy and Strategy, Page 9), highlighting the importance trained CHWs contributes towards malaria diagnosis and treatment at community level.



Why this curriculum?
This curriculum is developed for training CHWs & CHS on CBMM. As mentioned above the Government of Afghanistan is committed to control malaria in Afghanistan. Introduction of RDTs for early diagnosis of malaria and establishment of CBMM at community level are key interventions that will reduce morbidity and mortality of malaria. This curriculum will help to enhance their knowledge about malaria as well as it will build their confidence to introduce RDT for early diagnosis and ACT for treatment of falciparum malaria at community level.
Chapter one:

General information about malaria & approach to a malaria suspected patient

What is malaria-

  • Malaria is a vector borne parasitic febrile communicable disease.

Symptoms of malaria

  • The main symptom is fever

  • Fever may result in chills

  • Fever appears at the same time of the day

  • Fever disappears with sweating

  • After the disappearance of fever individual feels well/ healthy

  • Other signs and symptoms of malaria are:

    • Headache

    • Joint and body pain

    • Shivering

    • Vomiting

    • Diarrhoea (especially in children)

Causative agent of malaria:

  • Malaria is caused by a parasite called Plasmodium. There are four main types of Plasmodium. These are-

  • Plasmodium falciparum (Pf)

  • Plasmodium vivax (Pv)

  • Plasmodium malariae (Pm)

  • Plasmodium ovale (Po)

  • In Afghanistan Pv is more prevalent than Pf

Vector of malaria:

  • Female anopheles mosquito is the vector of malaria

Mode of transmission:

  • Female anopheles bites a malarial patient and gets Plasmodium with blood

  • This infected mosquito bites a healthy individual and introduces Plasmodium into the blood.

  • Malaria undergoes a sexual cycle inside the infected individuals

  • After a period of time the healthy individual suffers from malaria






Figure: Mode of transmission of malaria
Diagnosis of malaria: malaria can be diagnosed

  • Clinically

  • By microscopic examination of blood of the suspected person

  • By using RDT (Rapid Diagnostic Test)
Prevention of malaria:
There are three main ways in which we try to reduce the spread of malaria:

  • Treat people who are sick with malaria quickly so that the microorganisms cannot be sucked up by a mosquito,

  • Reduce the numbers of mosquitoes by controlling their breeding sites, and

  • Preventing mosquito bites by using bed nets with insecticide.

The most effective method is the use of long lasting insecticidal nets.

Approach to the patient:

Step 1. Register the patient. If the CHW is illiterate the family member or patient or patient’s family member will help to register the patient.

Step 2. Please follow the procedures


  1. ASK about : ( ask the patient or guardian in case of children)

  • The chief complaints: fever, headache, earache, throat pain, chilling, vomiting, cough, breathing difficulties, burning micturition.

  • Present illness: explanation of the above symptoms eg patient complains of fever and CHW must enquire after the fever history

  • Past history of the complaints: History of body feeling hot within 2-3 days, duration of the symptoms

  • History of past illness: history of past episode of fever, malaria etc

  1. LOOK:

  • Observe the appearance- ill looking/ unconsciousness/ drowsiness/ stable

  1. FEEL:

  • Use the back of your palm to check if the patient’s forehead feels hot

  1. Inspect the patient for : (more emphasise in case of children)

  • Ear discharge ( ask about ear pain)

  • Infection of the skin

  • Fast breathing / breathing difficulties

  • Sore throat ( ask about throat pain)

  1. TEST

  • Measure body temperature with thermometer from armpit (≥37.5°C/99.5° F or above) if the patient has fever

  • Use RDT (if needed)


Action to be taken By CHW:

  1. If the patient’s symptoms are similar to that of malaria and his/her condition is stable without any danger sign, use RDT. Treat the patient with ACT or Chloroquine if the result is positive for the malaria test. Give the first dose instantly.

  2. Refer the patient with danger signs to the nearest health facility.


The danger signs are:

  • He/she is uunable/unwilling to drink or feed (breastfeeding for children)

  • He/she vomits everything

  • History of convulsions

  • Presence of Lethargy / drowsiness / unconsciousness

  • she is severely anaemic

  1. Refer the patient of less than 5 months age with RDT positive result to the nearest health facility.

  2. Refer the pregnant women (1st trimester) with RDT positive result to the nearest health facility.


N.B. Please follow the malaria flow chart and treatment guideline.

Chapter Two

Introduction of RDT
What is RDT (Rapid Diagnostic Test)

RDT is a malaria diagnostic device that detects malaria specific protein (antigens) which is produced by malaria parasites.

It has


  • Space A for buffer

  • Space S for blood sample

  • Window C for control

  • Window test for Pf or PAN (Plasmodium another- P. vivax, or P. malaria or P. ovale) result


Advantages of RDT:

  • No need for laboratory facilities

  • Easy to carry

  • Simplicity and rapidity of the tests.

  • No need for electricity or laboratory equipment.

  • Minimal requirement for training (basic skills acquired in 1 day).

  • Acceptable levels of sensitivity and specificity, and

Disadvantages of RDT:

  • More expensive than microscopy.

  • Prolonged positive result after effective treatment.

  • Storage conditions of RDTs

Procedure of RDT use:

1-Prepare the materials needed



  • RDT

  • new, unopened lancet

  • Alcohol swab

  • disposable gloves

  • timer or watch

  • Safety box

  • Pencil or marker for labeling the RDT

  • Record book and pen for results

Take time to explain briefly to the patient what you are going to do

2- Check


- Expiration date of the RDT

- Colour of desiccant



DO NOT use expired damaged RDT or if there is a sign of exposure to humidity!

3- Wear disposable gloves.

Doing the test (1)


  1. Open the RDT packet and take out device just before use

  2. Label RDT with patient’s name or ID before doing the test

  3. Clean the patient’s finger with an alcohol swab and let it dry before doing a finger prick

  4. Discard used lancet immediately in the safety box

  5. Touch the surface of the blood with the collecting tube/device to get 5mL of blood

DO NOT collect too much blood as this may affect the test result

6) Slowly deliver the blood from the collecting tube onto the sample wall (S)

7) Discard the used blood collecting tube immediately in the sharp box

8) Invert the buffer bottle vertically and slowly dispense the required number of



drops into the buffer well (A)

9) Wait for the prescribed time (e.g.15-20 minutes) before reading the results



Storage of RDT:

  • Keep RDTs in the coolest part of the room, but never freeze them. They do not need refrigeration

  • Protect RDTs from excessive heat (Keep it within 40-300 C)

  • Store away from direct sunlight

  • Do not store close to a wall or ceiling, as both absorb heat during the day

  • Store a minimum of 30 cm away from walls and ceiling

  • Do not store directly on the ground

  • To reduce damage from moisture, water, and pests, store on a shelving unit or shelf, if possible

Chapter Three:

Practical use of RDT
Technique of the blood collection:

  • Take alcohol swab and clean the patient’s finger

  • Let it dry before the pricking

  • Open the lancet

  • Prick the finger with lancet

  • Discard the lancet in to the sharp box

  • Swab the first drop of blood

  • Press the pricked finger for second drop of blood

  • Touch the surface of the blood with the collecting tube to get 5mL of blood

  • Slowly deliver the blood from the collecting tube on to the sample wall (S)

  • Discard the used blood collecting tube immediately in the safety box

Practical use of RDT:

  • Participants will follow the instruction of RDT use (mentioned above)

  • They will follow the given Pictorial procedure of RDT use

  • They will apply on patients

  • Otherwise they will form groups and do the practical on each other.


Interpretation of the result:

  • Invalid result (the test device is invalid):

  1. No line in the control window or

  2. No line in the control & test window


Picture of RDTs with result mentioned above



  • Valid result( the test device is valid):

  1. Red line only in the control window or

  2. Red line in the control & test window


Picture of RDTs with result mentioned above



  • Negative result

  1. Red line in the control window and

  2. No line in the test window


Picture of RDTs with result mentioned above



  • Positive result

  1. Red line in the control window and

  2. Red line in the test window


Picture of RDTs with result mentioned above

Interpretation of positive result:



  1. Red line in control window & in Pf line of test window – Pf malaria case

  2. Red line in control window & in PAN line of test window – Pv malaria case

  3. Red line in control window , in Pf line & PAN line of test window – mix infection


Picture of RDTs with result mentioned above

After doing the test

1) Discard used gloves, swab, and desiccant in a non-sharp waste container

2) Keep used RDTs in the box. Return used RDTs for replacement with new RDTs

3) Record results in the register.
Chapter Four:

Treatment of malaria

What is ACT:

ACT - it is artemisinin combination therapy. It includes Artesunate 50/100mg + SP (sulfadoxine500 mg +Pyrimathamine 25 mg).

Treatment of P. falciparum malaria:

Artesunate(50 mg or 100 mg ) and SP( sulfadoxine500 mg +Pyrimathamine 25 mg) the recommended drugs for effective malaria treatment in Afghanistan



Dosage Chart




First Day

Second day

Third day


Remarks

Age

SP

Artesunate

Artesunate

Artesunate

5-11 months


Half tablet

Half tablet

Of 50 mg


Half tablet

Half tablet

Child


blister

1-6 years


One tablet

One tablet

Of 50 mg


One tablet

One tablet

7-13 years


Two tablets

Two tablets

Of 50 mg


Two tablets

Two tablets

Above 13 years


Three tablets

Two tablets

Of 100 mg



Two tablets

Two tablets

Adult blister

Important;



  • Day1 dose should be administrated as a Direct Observation therapy(DOT)

  • Remind the patient to complete the treatment.

  • Advice the patient to sleep under a long lasting insecticidal net to prevent Malaria attack

Note

The dose chart is only applicable for:

Blister 1: adult blister

Artesunate 100 and sulfadoxin +Pyrimthamine 500mg+25mg TABLET

Blister 2 Children Blister

Artesunate 50 mg and Sulfadoxin + Pyrimethamine 500 mg + 25 mg TABLET



Treatment of P. vivax malaria:

Chloroquine (150mg base tablet)



Age

(years)


Weight

(kg)


DAY 1

(no. of tablets)



DAY 2

(no. of tablets)



DAY 3

(no. of tablets)



<1

<10

½

½

½

1-<3

10-<14

1

1

½

3 –< 5

14-19

1 ½

1 ½

½

5-11

20-35

2 ½

2 ½

1

11-12

36-50

3

3

2

14+

50+

4

4

2


(Source: Revised National Treatment Guideline, April, 2010)
Treatment of mix infection: Treat as Pf malaria.

Malaria Flow Chart At Health Post Level

  • Registration of the patient

  • Use RDT



RDT positive (Pf/PAN)



RDT negative


Patient Stable.

Treat the patient

Patient with danger sign

Refer to health facility



Children less than 5 month.

Refer to health facility



Pregnant women (1st trimester)

Refer to health facility


Treat the patient as usual according to CHWs guideline




If Pf positive treat with ACT



If both Pf & PAN positive treat with ACT

If only PAN positive treat with Chloroquin-e

Pregnant women (2nd & 3rd trimester) If only PAN positive treat with Chloroquine

Pregnant women (2nd & 3rd trimester) If only Pf or both Pf & PAN positive treat with ACT




Patient comes back with symptoms after treatment


Refer the patient to the nearest health facility



Chapter five:
Session 1: WELCOME and INTRODUCTION

During this session, the participants will:

  • Register

  • Introduce each other

  • Share their expectations of the training

  • Introduce with the rules & norms of the training

  • Undertake a pre-test

  • Introduce about goal & objectives of the training

  • Know about the general information of malaria

Objective:

At the end of the session the participants will be able to



  • Define malaria

  • Describe signs & symptoms of malaria

  • Identify the causative agent of malaria

  • Name the vector of malaria

  • Describe the mode of transmission of malaria

  • List the main malaria prevention methods.

Method:

  • Question and answer

  • Pictorial presentation

  • Lecture with discussion

Topics:

General Information about malaria



  • What is malaria

  • Signs & Symptoms of malaria

  • Causative agent of malaria

  • Vector of malaria

  • Mode of transmission of malaria

  • Prevention of malaria

Materials:


  • Note books

  • Pen, Pencil

  • Posters/ Pictures

  • Flip Chart



Session 2: Introduction of Rapid Diagnostic Test

Objective:

At the end of the session the participants will able to



  • Know what is RDT

  • Describe advantages & disadvantages of RDT

  • Use RDT to diagnose malaria

  • Store RDT at health post level

Methods:

  • Demonstration of RDT

  • Question and answer

Topics:


  • What is RDT

  • Advantage and disadvantage of RDT

  • Procedure of RDT use

  • Storage of RDT




Materials:

  • RDT Kits

  • Pictorial instruction about RDT use

  • Safety box

  • Register form


Session3: Practical use of RDT
Objective:

At the end of the session the participants will able to



  • Collect patient’s blood for RDT

  • Use RDT for diagnosis of malaria

  • Interpret the result of RDT

Method:

  • Practical group work

  • Practical use of RDT

Topic:

  • Technique of blood collection from patient’s finger

  • Use of RDT for malaria diagnosis

  • Interpretation of the result of RDT

Material:

  • RDT

  • Lancet

  • Alcohol swab

  • Buffer

  • Dropper

  • Pictorial instruction about RDT use

  • Timer/ Watch


Session 4: Management of malaria
Objective:

At the end of the session the participants will able to



  • Define ACT

  • Treat the falciparum malaria cases by using ACT



Methods:

  • Lecture with discussion

  • Demonstration of ACT

  • Role play

Topics:

  • Introduction of ACT

  • Treatment of malaria by using ACT

Materials:

  • ACT (Dosage forms)

  • Pictorial demonstration of ACT, Dosage & treatment

Session 5: Reporting on RDT, ACT & malaria cases


Objective:

At the end of the session the participants will able to



  • Report on used RDT, positive & negative RDT

  • Report on ACT use

  • Report on malaria cases


Methods:

  • Demonstration of reporting formats

  • Small group discussion


Topics:

  • Reporting system about RDT

  • Reporting system about ACT use

  • Reporting system about malaria cases

Materials:

  • Different kinds of reporting formats


Session 6: Reporting on RDT, ACT & malaria cases
Methods:

  • Question and answer

  • Discussion


Topics:

  • Review of the previous lessons

  • Post test

  • End evaluation of course

Materials:

  • Post test sheet

  • Course evaluation sheet

1 Community-Based Health Care Policy and Strategy (2009-2013)

2 WHO (2004) Report of the Third Intercountry Meeting of National Malaria Control Managers, Lahore, Pakistan, 12-15 May 2003. World Health Organisation, Geneva, Switzerland (WHO-EM/MAL/297/E/05.04/140).


3 Integrated management of childhood illness: caring for newborns and children in the

Community WHO, 2010

* Refer to CHC for anti- relapse therapy of PV with Primaquine



4 Khohistani K, Nadeeb, S, Leslie T. Home Based Management of Malaria through the BDN (Basic Development Needs) Program in North-East and Eastern, regions of Afghanistan. TDR Final Technical Report, 2008

5 Health Protection and Research Organisation / ACT Consortium, Afghanistan (LSHTM). Effectiveness of community level deployment of rapid diagnostic tests for malaria in Afghanistan: Cluster Randomised Trial. Trail Protocol (in progress).

6 How to use a rapid diagnostic test (RDT): A guide for training at a village and clinic level. 2008.

The USAID Quality Assurance Project (QAP), University Research Co., LLC, and



the World Health Organization (WHO), Bethesda, MD, and Geneva.



Download 5.6 Mb.

Share with your friends:
1   2   3   4   5   6   7   8




The database is protected by copyright ©ininet.org 2024
send message

    Main page